Humans are unreliable models of mouse disease
Author:
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Allergy and Infectious Diseases (AI167047, AI167933)
- AbbVie
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR070116, AR080392, AR077007)
This publication has 8 references indexed in Scilit:
- Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trialsNature Medicine, 2023
- Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone creamJournal of Allergy and Clinical Immunology, 2020
- Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid ArthritisJAMA Dermatology, 2019
- Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic ItchCell, 2017
- JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndromeJournal of Allergy and Clinical Immunology, 2017
- Basophils Promote Innate Lymphoid Cell Responses in Inflamed SkinThe Journal of Immunology, 2014
- TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin InflammationScience Translational Medicine, 2013
- Defining Translational Research: Implications for TrainingAcademic Medicine, 2010